Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)NBM-BMX Administered Orally to Patients with Solid Tumors or Newly Diagnosed Glioblastoma
Phase 1
Recruiting
- Conditions
- Malignant Neoplasm of BrainMalignant Neoplasm
- Interventions
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Novelwise Pharmaceutical Corporation
- Target Recruit Count
- 79
- Registration Number
- NCT06012695
- Locations
- 🇨🇳
Hualien Tzu Chi Hospital, Hualien City, Taiwan
🇨🇳Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
🇨🇳Taichung Veterans General Hospital, Taichung City, Taiwan
News
No news found